Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential ; day:12 ; month:1 ; year:2018 ; pages:1-15
Clinical pharmacokinetics ; (12.1.2018), 1-15
- Keyword
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Creator
-
Schultze-Mosgau, Marcus-Hillert
- Contributor
-
Höchel, Joachim
Prien, Olaf
Zimmermann, Torsten
Brooks, Ashley
Bush, Jim
Rottmann, Antje
SpringerLink (Online service)
- DOI
-
10.1007/s40262-017-0607-4
- URN
-
urn:nbn:de:1111-201803163229
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schultze-Mosgau, Marcus-Hillert
- Höchel, Joachim
- Prien, Olaf
- Zimmermann, Torsten
- Brooks, Ashley
- Bush, Jim
- Rottmann, Antje
- SpringerLink (Online service)
Other Objects (12)
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Drug−Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management